Judge Shuts Down Actimmune Marketing MDL
A federal judge has brought an end to multidistrict litigation claiming biotechnology company InterMune Inc. fraudulently promoted its drug Actimmune as a remedy for a deadly lung disease it was not...To view the full article, register now.
Already a subscriber? Click here to view full article